Should I inject peptides on an empty stomach?
For GH secretagogues, yes — high blood glucose blunts GH release. For BPC-157, TB-500, and most others, food state doesn't matter. It's peptide-specific.
Updated May 8, 2026 · 5 min read
For GH-releasing peptides (sermorelin, ipamorelin, CJC-1295, tesamorelin), yes — inject on a relatively empty stomach because elevated blood glucose and insulin blunt the GH pulse. For BPC-157, TB-500, MOTS-c, GHK-Cu, and IGF-1 LR3, food state does not meaningfully affect efficacy. The "empty stomach" rule is specific to the GH-axis peptides; applying it universally is folklore, not pharmacology.
The peptide-by-peptide table
| Peptide | Empty stomach matters? | Why |
|---|---|---|
| Sermorelin | Yes | GHRH analog — glucose/insulin blunt GH pulse |
| Ipamorelin | Yes | GH secretagogue — same mechanism |
| CJC-1295 (no DAC) | Yes | GHRH analog — same mechanism |
| CJC-1295 with DAC | Less critical | Long half-life smooths food-state variation |
| Tesamorelin | Yes | GHRH analog — same mechanism |
| MK-677 (oral) | Yes | GH secretagogue — fasted dosing common |
| BPC-157 | No | Tissue-repair peptide; not GH-axis |
| TB-500 | No | Cytoskeletal/migration peptide; not GH-axis |
| MOTS-c | No | Mitochondrial peptide; food state irrelevant |
| IGF-1 LR3 | No | Already downstream of GH; food doesn't blunt it |
| GHK-Cu | No | Copper-peptide for skin/tissue; not metabolic |
The rule of thumb: if the peptide's job is to release GH, food matters. If the peptide's job is anything else, food doesn't matter.
Why empty stomach matters for GH peptides
Endogenous growth hormone is released in pulses, and the size of each pulse is regulated by competing signals. Two of those signals are blood glucose and insulin:
- High blood glucose suppresses GH release at the pituitary
- Elevated insulin independently blunts GH amplitude
- Free fatty acids (rise during fasting) sensitize GH release
When you inject a GHRH analog or GH secretagogue into a fed state, the drug is doing its job at the pituitary — but the pituitary is already being told by glucose and insulin to keep GH suppressed. The result is a smaller pulse than you'd get in a fasted state.
Practical consequences:
- Pre-meal or fasted dosing preserves pulse amplitude
- Post-carbohydrate-meal dosing measurably blunts the response
- Pure protein and fat have less effect than carbohydrate, but still some
For more on timing for these specifically, see best injection timing for GH secretagogues.
What "empty stomach" means in practice
You don't need to be 12-hour fasted. The practical window most users target:
| Window | Sufficient for GH peptides? |
|---|---|
| No food in last 30 min | Marginal — recent carbs still in play |
| No food in last 2 hours | Adequate for most users |
| No food in last 3+ hours | Optimal — glucose and insulin near baseline |
| Fasted overnight | Optimal |
The two cleanest dosing windows for GH peptides:
- First thing in the morning, before breakfast — overnight fast already achieved
- Before bed, 2-3 hours after the last meal — naturally aligns with the largest endogenous GH pulse
The pre-bed window is especially common because GH release naturally peaks in the first few hours of sleep. Augmenting that pulse stacks well with the natural rhythm.
What about post-injection eating?
The rule is "fasted before injection." Once you've injected and the GH pulse has been triggered (typically within 15-30 minutes), eating is fine — the GH pulse has already happened. Most protocols specify:
Before: at least 2 hours fasted
After: wait 20-30 minutes, then eat normally
Some users target an additional fasted window post-injection to extend the elevated GH state, but evidence for this is thin. The pulse fires once; sustaining a fasted state for hours afterward doesn't lengthen it meaningfully.
Why food doesn't matter for non-GH peptides
| Peptide | Mechanism | Food interaction |
|---|---|---|
| BPC-157 | Local angiogenesis, growth factor signaling | None known |
| TB-500 | Actin reorganization, stem-cell migration | None known |
| MOTS-c | Mitochondrial signaling | Mild — not timing-critical |
| IGF-1 LR3 | IGF-1 receptor agonist | None — bypasses GH axis |
| GHK-Cu | Local skin/tissue copper signaling | None |
The pharmacology for these is local or systemic but not gated through the GH-glucose-insulin loop. You can inject any of them after lunch, before dinner, mid-afternoon — none of it changes efficacy.
The one minor exception is IGF-1 LR3 timing relative to training. Some users time IGF-1 LR3 around the post-workout window to align with the anabolic signaling state, but this is convention, not strong evidence. Empty-stomach is not part of that consideration.
Common mistakes around fasting and peptides
| Mistake | What goes wrong |
|---|---|
| Fasted-injecting BPC-157 thinking it matters | Doesn't hurt, but unnecessary discipline cost |
| Eating a high-carb meal 30 min before sermorelin | Blunts the GH pulse meaningfully |
| Skipping breakfast just to dose IGF-1 LR3 | No mechanism — wasted fasting |
| Treating the rule as "don't eat for 4 hours after" | Way more strict than evidence supports |
| Applying it to GHK-Cu | Topical/local peptide; food irrelevant |
The actionable rule: know whether your peptide is GH-axis or not. If yes, time it around fasting windows. If no, inject when it's convenient.
A practical timing schedule
A common stack for someone running BPC-157 + a GH peptide:
| Time | What |
|---|---|
| 7:00 AM | Wake; BPC-157 injection (food-state irrelevant); breakfast 30 min later |
| Throughout day | Normal eating |
| 9:30 PM | Last food at this point — light dinner ended ~7 PM |
| 10:30 PM | Ipamorelin / CJC-1295 injection (3+ hours after dinner) |
| 11:00 PM | Sleep — natural GH pulse augmented by injection |
This pattern keeps the food-state-sensitive peptide in its optimal window and lets the food-state-insensitive peptide go whenever fits the routine.
For more on timing within stacks, see stacking and cycling peptides.